Predictors of Response in Secukinumab-treated Patients with Ankylosing Spondylitis: Logistic Regression and Machine Learning Analyses

被引：0
|
作者：
Miceli-Richard, Corinne [1 ]
Poddubnyy, Denis [2 ]
Deodhar, Atul [3 ]
Bao, Weibin [4 ]
Parman, Craig [5 ]
Porter, Brian [6 ]
Pournara, Effie [5 ]
机构：
[1] Paris Descartes Univ, Hop Cochin, AP HP, Dept Rheumatol, Paris, France
[2] Charite Univ Med Berlin, Berlin, Germany
[3] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[4] Novartis Pharmaceut, East Hannover, NJ USA
[5] Novartis Pharma AG, Basel, Switzerland
[6] Novartis Pharmaceut, E Hanover, NJ USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2020年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1893
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Testing and Validating Two Morphological Flare Predictors by Logistic Regression Machine Learning
    Korsos, M. B.
    Erdelyi, R.
    Liu, J.
    Morgan, H.
    FRONTIERS IN ASTRONOMY AND SPACE SCIENCES, 2021, 7
  • [22] GETTING THE REAL EXPERIENCE: PATIENTS WITH PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS TREATED WITH SECUKINUMAB AT THE ARMY HOSPITAL OF SANTIAGO, CHILE
    Grunholz Gambi, Daniela
    Wainstein Gurovich, Eduardo
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2019, 25 : S68 - S68
  • [23] Spinal radiographic progression over 2 years in ankylosing spondylitis patients treated with secukinumab: a historical cohort comparison
    J. Braun
    H. Haibel
    M. de Hooge
    R. Landewé
    M. Rudwaleit
    T. Fox
    A. Readie
    H. B. Richards
    B. Porter
    R. Martin
    D. Poddubnyy
    J. Sieper
    D. van der Heijde
    Arthritis Research & Therapy, 21
  • [24] IMPACT OF HLA-B27 STATUS ON CLINICAL OUTCOMES AMONG PATIENTS WITH ANKYLOSING SPONDYLITIS TREATED WITH SECUKINUMAB
    Deodhar, A.
    Mease, P. J.
    Poddubnyy, D.
    Calheiros, R.
    Meng, X.
    Strand, V.
    Magrey, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 717 - 717
  • [25] No Increased Risk of Inflammatory Bowel Disease Among Secukinumab-Treated Patients with Moderate to Severe Psoriasis, Psoriatic Arthritis, or Ankylosing Spondylitis: Data from 14 Phase 2 and Phase 3 Clinical Studies
    Deodhar, Atul A.
    Schreiber, Stefan
    Gandhi, Kunal
    Fox, Todd
    Gaillez, Corine
    Karyekar, Chetan
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [26] Machine learning to predict early TNF inhibitor users in patients with ankylosing spondylitis
    Lee, Seulkee
    Eun, Yeonghee
    Kim, Hyungjin
    Cha, Hoon-Suk
    Koh, Eun-Mi
    Lee, Jaejoon
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [27] Machine learning to predict early TNF inhibitor users in patients with ankylosing spondylitis
    Seulkee Lee
    Yeonghee Eun
    Hyungjin Kim
    Hoon-Suk Cha
    Eun-Mi Koh
    Jaejoon Lee
    Scientific Reports, 10
  • [28] NO INCREASED INCIDENCE OF INFLAMMATORY BOWEL DISEASE AMONG SECUKINUMAB-TREATED PATIENTS WITH MODERATE TO SEVERE PSORIASIS, PSORIATIC ARTHRITIS, OR ANKYLOSING SPONDYLITIS: DATA FROM 14 PHASE 2 AND PHASE 3 CLINICAL STUDIES
    Schreiber, S.
    Sands, B. E.
    Deodhar, A.
    Baeten, D.
    Huang, J.
    Gandhi, K.
    Karyekar, C.
    Fox, T.
    Gaillez, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 97 - 98
  • [29] NO INCREASED RISK OF INFLAMMATORY BOWEL DISEASE AMONG SECUKINUMAB-TREATED PATIENTS WITH MODERATE TO SEVERE PSORIASIS, PSORIATIC ARTHRITIS, OR ANKYLOSING SPONDYLITIS: DATA FROM 14 PHASE 2 AND PHASE 3 CLINICAL STUDIES
    Zochling, J.
    Deodhar, A.
    Schreiber, S.
    Gandhi, K.
    Fox, T.
    Gaillez, C.
    Karyekar, C.
    INTERNAL MEDICINE JOURNAL, 2017, 47 : 38 - 39
  • [30] MACHINE LEARNING TO PREDICT EARLY TNF INHIBITOR USERS IN PATIENTS WITH ANKYLOSING SPONDYLITIS
    Lee, J.
    Kim, H.
    Kang, S. Y.
    Lee, S.
    Eun, Y. H.
    Cha, H. S.
    Koh, E. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1616 - 1617
12345